Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Anastasia, Ermakova"'
Autor:
Oksana, Raskosha, Anatoly, Karmanov, Anastasia, Ermakova, Lyudmila, Bashlykova, Yana, Pylina, Natalia, Starobor, Irina, Bodnar, Elena, Rasova, Ludmila, Kocheva
Publikováno v:
In International Journal of Biological Macromolecules December 2024 283 Part 1
Autor:
Anastasia Ermakova
This article is the results of the research, aimed to train, test and use custom neural network effortlessly, without spending huge amountof time and efforts to prepare special training set or to test trained neural network performance. I have submit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cb0492a0b9d749a1bb48ae1562c55575
https://doi.org/10.14293/s2199-1006.1.sor-.ppueph0.v1
https://doi.org/10.14293/s2199-1006.1.sor-.ppueph0.v1
Publikováno v:
The American Journal of Managed Care. 27:e349-e354
Objectives Residents with diabetes in long-term care (LTC) settings often have recognized risk factors for developing hypoglycemia, including advanced age, dementia, and polypharmacy; however, data regarding hypoglycemia in LTC and associated hospita
Autor:
Marina Slukovskaya, Maria V. Korneykova, Olga Gavrichkova, Andrey Novikov, Anastasia Ermakova, Olesya Sazonova, Anna Vetrova, Viacheslav Vasenev, Kristina Ivashchenko
Phylloplane or the microbial habitat on leaf surfaces is an integrated part of green infrastructure, with the potential to stimulate plant community productivity, affect plant fitness, and release of ecosystem services. Anthropogenic pressure, among
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::481151f141d7e1f87322365f24aa5d5b
https://doi.org/10.5194/egusphere-egu21-5206
https://doi.org/10.5194/egusphere-egu21-5206
Publikováno v:
Journal of managed carespecialty pharmacy. 25(12)
Persistence with multiple daily insulin injections (MDI) may be challenging for patients with type 2 diabetes (T2DM). However, limited information is available regarding the effect of persistence with MDI on outcomes.To evaluate persistence with basa
Publikováno v:
Proceedings of the Karelian Research Centre of the Russian Academy of Sciences. :91
Autor:
Anouk van Westrhenen, Anastasia Ermakova, Aislyn C. DiRisio, Linda Dirven, Eman Nassr, Martin J B Taphoorn, Maya Harary, Rania A. Mekary, Timothy R. Smith, Marike L. D. Broekman
Brain metastases (BMs) have become increasingly prevalent and present unique considerations for patients, including neurocognitive sequelae and advanced disease burden. Therefore, assessing health-related quality of life (HRQoL) via patient-reported
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::180b3b2b0c46be3c5e9997fb4fcd1f3d
https://hdl.handle.net/1887/116655
https://hdl.handle.net/1887/116655
Autor:
Diana I. Brixner, Naomi C. Sacks, Yan Xiong, Anastasia Ermakova, Philip L. Cyr, Stephanie D. Taylor, Ray Sieradzan
Publikováno v:
Clinical therapeutics. 41(2)
Purpose Therapy for patients with type 2 diabetes (T2DM) not achieving hemoglobin (Hb) A1c targets may progress from an oral antidiabetic drug (OAD) to added basal insulin and then to multiple daily injections of basal-bolus insulin (MDI); however, t
Autor:
Yan Xiong, Philip L. Cyr, Thomas Ludden, Ray Sieradzan, Naomi C. Sacks, Stephanie D. Taylor, Shay Phillips, Anastasia Ermakova
Publikováno v:
Diabetes. 67
Objective: We retrospectively analyzed clinical outcomes in type 2 diabetes mellitus (T2DM) multiple daily injections (MDI) insulin therapy patients compared with non-MDI insulin therapy patients. MDI was defined as patients having at least one basal
Publikováno v:
Value in Health. 22:S146